News
-
-
-
PRESS RELEASE
VALBIOTIS SA: Cardiovascular Prevention Act: A response to a major public health challenge A milestone fully aligned with Valbiotis’ mission
Valbiotis welcomes the final adoption of the Cardiovascular Prevention Act by the French Parliament, emphasizing prevention of cardiovascular and neurovascular diseases in France's national strategy -
-
-
PRESS RELEASE
VALBIOTIS SA: Results of the REVERSE-IT clinical study published in Nature Communications, a major international scientific recognition for the ingredient Totum•63
Results of the REVERSE-IT clinical study published in Nature Communications, showcasing significant benefits of Totum•63 in cardiometabolic health -
-
-
-
